SIDLEY AUSTIN LLP

Lobbying for ANNEXON BIOSCIENCES · Pharmaceutical manufacturer

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income · posted Jul 18, 2025

Lobbying activity 1

Health Issues

Rare disease policy, drug approval process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem